Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: Allogenic Islet Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes an active non-recruiting Phase 1/2 study evaluating allogeneic islet cell transplantation for type 1 diabetes, sponsored by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic islet cell transplantation

Snippet

Sponsor: University of Chicago | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING